These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Distribution of exogenous and endogenous L-asparaginase in mice]. Wierer U; Pütter J Arzneimittelforschung; 1972 Apr; 22(4):791-5. PubMed ID: 5068262 [No Abstract] [Full Text] [Related]
4. Uptake of drug-resistant tumour cell fractions by drug-sensitive tumour cells. Ujhăzy V; Kuzela S; Krempasky V; Bohunickă E Neoplasma; 1971; 18(6):627-30. PubMed ID: 5172114 [No Abstract] [Full Text] [Related]
5. Comparison of antitumor effect of recombinant L-asparaginase with wild type one in vitro and in vivo. Guo QL; Wu MS; Chen Z Acta Pharmacol Sin; 2002 Oct; 23(10):946-51. PubMed ID: 12370101 [TBL] [Abstract][Full Text] [Related]
9. Biochemical method of cancer control. L-asparaginase in cancer chemotherapy. A review. Jayaram HN; Sirsi M Indian J Cancer; 1970 Mar; 7(1):71-7. PubMed ID: 4992298 [No Abstract] [Full Text] [Related]
10. [Nutritional requirement of cancer cells: inhibition of the growth of cancer cells by L-asparaginase]. Honjo T; Hayaishi O Tanpakushitsu Kakusan Koso; 1970 Apr; 15(5):515-23. PubMed ID: 4913828 [No Abstract] [Full Text] [Related]